Physician profile
Daniel J Hulse
NPI 1386842227
$300.77
in general payments reported to CMS, 2019-2025
6 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.00 · 2023: $29.26 · 2024: $54.70 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $168 · Food and Beverage: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $167.92 |
| Food and Beverage | $107.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $167.92 | 2025 | Optablate, Spinejack |
| Lilly USA, LLC | $52.86 | 2023-2024 | Mounjaro, Trulicity, Zepbound |
| Amarin Pharma, INC. | $25.00 | 2021 | |
| Radius Health, INC. | $23.89 | 2025 | Tymlos |
| Organogenesis INC. | $15.69 | 2023 | Puraply |
| Amgen INC. | $15.41 | 2024 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hulse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.